On July 8, 2022, David E Lazar sent a letter to Titan Pharmaceuticals Inc, requesting the Company to convene a special meeting, to call a special meeting of the Company's shareholders to increase the Company's board size by 6 members, and elect his board nominees Avraham Ben-Tzvi, Peter L. Chasey, Eric Greenberg, David E. Lazar, Matthew C. McMurdo and David Natan. In addition, David E Lazar requested that the Company immediately notice the Company's stockholders that the special meeting will be held on August 2, 2022, and that July 22, 2022, will be established as the record date for determining the Issuer's stockholders who are entitled to vote at the Special Meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.34 USD | -2.17% | -8.11% | -23.15% |
Apr. 01 | Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 26 | Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule | MT |
1st Jan change | Capi. | |
---|---|---|
-23.15% | 5.8M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- TTNP Stock
- News Titan Pharmaceuticals, Inc.
- David E Lazar Sends a Letter to Titan Pharmaceuticals Inc